VEREGEN

Serial Number 78862546
606

Registration Progress

Application Filed
Apr 17, 2006
Under Examination
Feb 20, 2007
Approved for Publication
Nov 8, 2006
Published for Opposition
Nov 28, 2006
Registered

Trademark Image

VEREGEN

Basic Information

Serial Number
78862546
Filing Date
April 17, 2006
Published for Opposition
November 28, 2006
Abandonment Date
September 21, 2009
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 21, 2009
Classes
005

Rights Holder

MEDIGENE AG

03
Address
Lochhamer Strasse 11
Martinsried
DE

Ownership History

MEDIGENE AG

Original Applicant
03
Martinsried DE

MEDIGENE AG

Owner at Publication
03
Martinsried DE

Legal Representation

Attorney
Linda M. Byrne

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
Sep 21, 2009 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 21, 2009 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Feb 9, 2009 EX4G S EXTENSION 4 GRANTED Loading...
Feb 6, 2009 EEXT I TEAS EXTENSION RECEIVED Loading...
Feb 6, 2009 EXT4 S EXTENSION 4 FILED Loading...
Aug 7, 2008 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 7, 2008 EX3G S EXTENSION 3 GRANTED Loading...
Jul 28, 2008 EEXT I TEAS EXTENSION RECEIVED Loading...
Jul 28, 2008 EXT3 S EXTENSION 3 FILED Loading...
May 7, 2008 EX2G S EXTENSION 2 GRANTED Loading...
Apr 23, 2008 PGEX O PETITION GRANTED - EXTENSION REQUEST FILED Loading...
Apr 18, 2008 APET A ASSIGNED TO PETITION STAFF Loading...
Apr 14, 2008 MAIL I PAPER RECEIVED Loading...
Apr 14, 2008 PETR I PETITION TO REVIVE-RECEIVED Loading...
Mar 11, 2008 CORV P REVIEW OF CORRESPONDENCE COMPLETE Loading...
Mar 11, 2008 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 11, 2008 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Mar 6, 2008 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Mar 6, 2008 FAXX I FAX RECEIVED Loading...
Mar 6, 2008 FAXX I FAX RECEIVED Loading...
Mar 6, 2008 FAXX I FAX RECEIVED Loading...
Mar 3, 2008 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 20, 2008 EXT2 S EXTENSION 2 FILED Loading...
Feb 8, 2008 MAIL I PAPER RECEIVED Loading...
Feb 8, 2008 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Dec 3, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 9, 2007 EEXT I TEAS EXTENSION RECEIVED Loading...
Aug 9, 2007 EXT1 S EXTENSION 1 FILED Loading...
Aug 9, 2007 EX1G S EXTENSION 1 GRANTED Loading...
Feb 20, 2007 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 28, 2006 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 8, 2006 NPUB O NOTICE OF PUBLICATION Loading...
Oct 6, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 5, 2006 ALIE A ASSIGNED TO LIE Loading...
Sep 29, 2006 ALIE A ASSIGNED TO LIE Loading...
Sep 22, 2006 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 22, 2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 21, 2006 NWAP I NEW APPLICATION ENTERED IN TRAM Loading...

Detailed Classifications

Class 005
Pharmaceutical products for topical application, namely, pharmaceutical preparations for use in treating the skin diseases of verruca vulgaris, verruca plantaris, verruca plana, flat condylomata, mosaic-type warts, butcher's warts, hyperplasia of the epidermis, recalcitrant cutaneous warts, herpes infection, genital and anal herpes infection, shingles, Molluscum contagiosum, mycosis, mycosis fungoides, tinea, tinea pedis, pigmentation disorders, hyperpigmentation, hypopigmentation, vitiligo, melasma, atypical/displastic/melanocytic nevi, sun-damaged skin, removal of tattoos, psoriasis, neurodermitis, dermatitis, atopic dermatitis, cutaneous atopy, eczema, lichen planus, cutaneous lupus erythematosus, skin ulcers, rosacea, precancerous and cancerous lesions, increased proliferation of skin cells, actinic keratosis, actinic cheilitis, keloids, lentigo, hemangioma, Epidermodysplasia verruciformis, Bowen's disease, Bowenoid papulosis, basal cell carcinoma, intraepithelial squamous cell carcinoma, melanoma, and other skin cancers, neoplasias, cervical dysplasia, cervical intraepithelial neoplasias, anal intraepithelial neoplasias, vulvar intraepithelial neoplasia, penile cancer, vulvovaginal cancer, anal carcinoma, cervical carcinoma, cutaneous T-cell lymphoma, alopecia, vulvodynia, keloid and hypertrophic scars, post surgical excision on scar cosmesis, hyperkeratosis, seborrhea, Darier's disease, porokeratosis of mibelli, ichthyosis, xerosis, dartroud disthesis, acne, nasal papilloma, oral papilloma, focal epithelial hyperplasia, laryngeal papilloma, recurrent respiratory papillomatosis and conjunctival papilloma
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005